Introduction
Osteoblasts and osteoclasts maintain bone homeostasis in a coordinated manner. Their differentiation and function are regulated by hormones and cytokines, and aberration of their cells causes metabolic bone diseases such as osteoporosis, osteopetrosis, paget's disease of bone and so on. Additionally, it is revealed M-CSF (macrophage colony stimulating factor) and RANK [receptor activator of nuclear factor (NF)-kB]/RANKL (RANK ligand) system are essential for cell-cell interaction between osteoblast-lineage cells and osteoclast-lineage cells [1] [2] [3] .
However, clarification of each cell function is still incomplete.
Osteoclasts perform their function of resorbing bone by adhering to bone via integrin receptors, dissolving bone matrix minerals using protons, and degrading organic materials with hydrolytic enzymes intra-and extracellularly 4) . Protons are produced from water and carbon dioxide by the activity of carbonic anhydrase II (CA II) at the cell membrane 5) and are actively transported into resorption pits through V-ATPase (proton pump) at the surface of ruffled border 6) . Proton production by CA II is indispensable for bone resorption and congenital defects in CA II function are known to cause human osteopetrosis 7) . Though acetazolamide (AZ), a sulfonamide inhibit CA II specifically and suppress bone resorption 8) , the influences in the survival of osteoclasts and osteoblasts are not clear. For that reason, the effects of AZ in the trabecular bone structure, the amount of osteoclasts and their morphology were examined at the cartilage-bone junction in tibiae of rats injected subcutaneously with AZ. We also analyzed the effects of AZ in the bone resorption by rat osteoclasts examining resorption pits, number of osteoclasts and their shape among bone marrow cell culture. In vitro study, we used parathyroid hormone (PTH) and bone slices to investigate the changes of osteoclasts in a similar environment to living body.
Furthermore we used coverslips to observe the morphology of osteoclasts clearly.
Materials and Methods

In vivo examination
Five-week-old male Sprague Dawley rats (Nihon Charles Abstract:We examined the changes of osteoclasts and bone structure in vivo and in vitro under the condition of low activity of bone resorption induced by acetazolamide (AZ). AZ is a specific inhibitor of carbonic anhydrase II (CA II), which is the enzyme indispensable for substantial proton generation by osteoclasts. In vivo study, we investigated histologically and histomorphometrically the changes of trabecular bone and osteoclasts at the cartilage-bone junction of tibiae in rats injected subcutaneously with AZ for 21 days. The area of trabecular bone of AZ treated group increased compared with control group. Moreover, AZ treatment decreased about 20% the number of osteoclasts at the cartilage-bone junction. In vitro study, we examined the effects of AZ on osteoclasts using culture system of rat bone marrow. The number of osteoclasts on the bone slice was suppressed by AZ of a concentration from 10 -5 to 10 -4 M in a doze-dependent manner. The number of osteoclasts cultured with 10 -4 M AZ for 24 hours and with or without parathyroid hormone (PTH) on the bone slice and on the glass showed a significant decrease compared with the control group. Some osteoclasts treated with AZ showed morphological changes of apoptosis-like cell death, including shrinking of cytoplasm and fragmentation of nuclei. These results show that high-doze of AZ decreases bone resorption not only by inhibiting CA II but also by decreasing the number of osteoclasts via induction of cell death. This suggests that CA II plays an important role not only in proton formation but also in osteoclast survival.
River, Kanagawa, Japan) were injected subcutaneously with AZ (Sigma Chemical Co., St. Louis, MO) or vehicle dimethylsulfoxide (DMSO, Wako Pure Chemical, Osaka, Japan) at a dose of 50 mg/ day per kgBW. The tibiae were removed on day 5, 7, 14 and 21, fixed in 10% formalin, demineralized with 10% EDTA, embedded in paraffin and cut at 5-µm in longitudinal sections. Three serial sections were placed on each slide glass. Each five slide glasses from the central portion of the tibiae, separated by an interval of 4 slide glasses, were stained with hematoxylin and eosin (HE) and tartrate-resistant acid phosphatase (TRAP), a typical enzyme marker of osteoclasts. Changes in trabecular bone were examined by HE staining, and the ratio of bone per unit area (290 µm 255 µm) subjacent to the epiphyseal plate was measured using a videomicrometer (Olympus, Tokyo, Japan).
For TRAP, deparaffined specimens were treated with ethanolacetone (50 : 50, vol/vol) for 1 min and stained using a modified method of Akatsu et al 9) . Briefly, an acetate buffer (0. 4 to 7 rats were sacrificed for each group.
In vitro examination
Osteoclasts were prepared according to the method of 
Assay for osteoclastic bone resorption activity
The cells were seeded on bone slices and incubated with AZ for 96 h. Then, cells were removed with a brush, and resorption pits formed by osteoclasts on bone slices were stained with acid hematoxylin (Sigma) for 5 min. Total area of resorption pits (indicator of bone resorption activity) was measured under an optical microscope.
Osteoclast morphology
Osteoclasts on bone slices or coverslips were stained for TRAP. 
Statistical analysis
The values are reported as mean SD, and statistical study was performed by using Student's unpaired t-test.
Results
Effects of AZ in vivo
Histological changes of tibiae in rats injected with AZ were examined. Width of the epiphyseal plate and cancellous tissue in the AZ rats were similar to those of the control rats, and no obvious Photomicrographs of HE staining in tibiae of rats at 21 days: control rats (A); and AZ-injected rats (B). Trabecular bone of tibiae in the control rats showed column-like structures parallel to the long axis (arrows). In the AZ-injected rats, adjacent poorly developed bone trabuculae with wide cartilage pillar were often fused together (arrow heads); bar=50 µm. (C) Effects of AZ on the ratio of trabecular bone. The ratio of trabecular bone in the AZ-injected rats ) was significantly greater than that of the control rats ( ) at 7 and 21 days after injection of AZ (*p<0.05). Highly magnification photomicrographs of HE staining in tibiae of rats at cartilage-bone junction at 21 days: control rats (A); and AZ-injected rats (B). In the AZ-injected rats, osteoblats lining trabecular bone showed spindle shape (arrow heads), while those of control group showed cube shape (arrows); bar=50 µm. between these 2 groups. However, trabecular bone subjacent to the epiphyseal plate differed in structure. In the control rats, trabecular bone was laid down on the cartilage as parallel pillars of uniform width (Fig. 1A) . In the AZ-treated rats, poorly developed bone trabeculae with wide cartilage pillar were fused to each other (Fig. 1B) . On day 7, 14 and 21, the area of trabecular bone was greater in the AZ-treated rats than in the control rats, indicating that resorption of trabecular bone was suppressed by AZ (Fig. 1C) . In the AZ group on 7 days after treatment, some osteoblats lining showed spindle-shaped, while those of control group showed cube-shaped (Fig. 2) .
The number of osteoclasts per unit area of longitudinal bone section was also counted. In both AZ and control sections of bone, many multinucleated cells were found, which were stained for TRAP and overlaid the resorption pits. However, the number of osteoclasts per unit area was statistically lower in the AZ-treated rats than in the control rats. AZ treatment for 7, 14 and 21 days produced about a 20% reduction in the number of osteoclasts (Fig.   3 ). Specifically, morphological apoptosis-like osteoclasts were not identified in bones from these animals (data not shown).
Effects of AZ on osteoclastic bone resorption
The cells were placed on bone slices and cultured with PTH, followed by addition of AZ and cultured for 96 h. In the control cultures, numerous resorption pits were formed and pit area increased with time. In the AZ cultures, pits were smaller and fewer than in the control cultures (Fig. 4A-D) . A significant dosedependent decreased in pit area was detected in the presence of 10 -5 to 10 -4 M AZ, and 10 -4 M AZ inhibited bone resorption completely (Fig. 4E) .
Effects of AZ on the number of osteoclasts
To determine the effects of AZ on the viability of osteoclasts, the cells were stained for TRAP. When cells were cultured with PTH on bone slices, the number of osteoclasts was reduced in a dose-dependent manner at 24 h. At 10 -4 M AZ, the number of osteoclasts was 34% of the control ( (Fig. 6A, B) . The number of osteoclasts on coverslips with PTH increased with time up to 14 h in control culture. On the other hand, AZ-treated osteoclast was slowly decreased (Fig. 6C) . Still more, the number of osteoclasts on coverslips without PTH did not increase and AZ-treated osteoclast was quickly decreased (Fig. 6D ).
Changes in cell morphology
Cells cultured on coverslips were stained for TRAP and treated with the nuclear dye DAPI. There were more osteoclasts with a markedly abnormal morphology in the AZ cultures than in the control cultures. Some AZ-treated osteoclasts contained smaller, brightly stained nuclei with chromatin condensation and/or nuclear fragmentation and cytoplasmic contraction, which showed apoptosis-like cell death (Fig. 7A, B) . Most of the osteoclasts in the control cultures demonstrated evidence of round and intact nuclei with diffuse homogeneous DAPI staining (Fig. 7B) . TUNEL assay, a method for in situ nick end-labeling of DNA fragments in cells, was used for further examination regarding cell death of osteoclasts on coverslips. A part of osteoclast showed strong signal in the condensed nuclear fragments and downsized cytoplasm (Fig.   7C , E), while no signal and shrinking were detected on normal cells (Fig. 7D, F) .
The number of osteoclasts attached to coverslips demonstrated presence of nuclear fragmentation, chromatin condensation of Photomicrographs of TRAP-stained tibiae of rats at 21 days: control rats (A); and AZ-injected rats (B); bar=50 µm. The density of osteoclasts in the AZ rats ( ) was significantly lower than that of the control rats ) on day 7, 14 and 21 (C) (*p<0.05, **p<0.01). (Fig. 8 ).
Discussion
The effects of AZ on bone metabolism have been reported. AZ inhibit 45 Ca release in organ culture 8, 11) , suppress bone resorption 12) and increase intracellular pH and Ca 2+ 13) . In the present study, AZ not only inhibited bone resorption activity by pit assay, but reduced the number of osteoclast in vivo and in vitro. Some reason why the number of osteoclasts reduced can be thought. First is promotion of cell death of osteoclasts, second is inhibition of new formation of osteoclasts and third is detachment of osteoclasts from bone surface. It is important by which caused in these decrease of osteoclasts.
In vitro study, the morphology of osteoclasts was investigated.
Osteoclasts cultured with AZ clearly showed evidence of nuclear fragmentation, chromatin condensation of nuclei and cytoplasmic contraction more than that of control group. These aspects represent some histological findings of apoptosis, so it is distinct from necrosis characterized by swelling of cytoplasm and plasma membrane integrity without severe damage to nuclei 14) . In the present study, it was clarified that reduction of the number of osteoclasts by AZ was mainly caused by induction of cell death of osteoclasts. However, apoptosis and some necrosis share common pathway to cell death partway 15) , thus it is necessary to confirm this cell death carefully with the use of further evidence by annexinV stain and caspase activation. Previous studies have indicated that apoptosis is induced in osteoclasts by bisphosphonate 16) , V-ATPase inhibitor 17) , Vitamin K 2 18) and estrogen 19) . Though the mechanisms by which osteoclast apoptosis is induced by these substances are still unknown, however these findings suggest that inhibition of bone resorption activity of osteoclast at any step induce apoptotic cell death of osteoclast.
Osteoclasts are formed by the fusing of pre-osteoclasts, which differentiate from multipotent stem cells, and they are activated by contact with osteoblastic cells to become active bone-resorbing osteoclasts [1] [2] [3] . We used bone marrow cells as the source of osteoclasts, so many kinds of cells containing osteoblastic cells existed in this culture system. These osteoblastic cells were considered to allow new osteoclast formation. Additionally PTH upregulate the expression of RANKL 20) , stimulate osteoclast formation 4) and promotes bone resorption by osteoclasts 21) . In the present study, the number of osteoclasts decreased even in the condition that formation of osteoclasts and inhibition of cell death were induced by PTH in bone marrow culture system, so it was indicated that reduction of the number of osteoclasts by AZ was caused by inhibiting the formation of osteoclasts too. Surely, CA II has been detected in pre-osteoclasts 22) and AZ inhibit 1,25-
]-stimulated formation of osteoclasts 13) . These findings supported our hypothesis that the decrease in osteoclast number in this study partly is due to suppressed osteoclast formation. Also PTH induces mRNA expression of CA II increased as much as 5-fold in pre-osteoclasts 23) . In this study, PTH reduced the rate of apoptosis-like cell death of AZ-treated osteoclasts about one-third. Consequently, it suggested that inhibition of AZ-induced apoptosis-like cell death Osteoclasts were cultured on coverslips with 10 -4 M AZ. Fluorescence photomicrographs of apoptosis-like (A, B; arrow head) and normal (B; arrow) osteoclasts. Cells were treated with TRAP and DAPI. Apoptosis-like osteoclasts indicated bright nuclear fragments; bar=50 µm. Apoptosis-like osteoclasts indicated DNA fragmentation by TUNEL assay (C; arrow head). Osteoclasts with no signal maintained normal shape (D; arrow); bar=50 µm. Apoptosis-like osteoclasts stained for TRAP and TUNEL showed condensed nuclear fragments and downsized cytoplasm (E; arrow head), while no signal and shrinking were detected in normal cells (F; arrow); bar=50 µm.
by PTH is a result from activated CA II and osteoclastogenesis caused by PTH.
Another possibility of decreased in the number of osteoclasts is detachment of osteoclasts from bone or coverslips. For example, it is reported that calcitonin inactivate osteoclasts by detaching from the bone surface 24) . We put conditioned culture medium of each sample into the centrifuge, spun it slowly and gathered cells
were assessed with a light microscope after TRAP staining. No intact or denatured osteoclasts were detected in conditioned culture medium. Podosome, a cell adhesion equipment which contain vinculin, talin and F-actin important for bone resorbing osteoclasts, exists when they cultured on both bone slices and coverslips 25, 26) .
This result indicates that AZ decreases the number of osteoclasts Apoptotics osteoclasts (%) Apoptotics osteoclasts (%)
